Status:
COMPLETED
Protein Supplementation to Enhance Exercise Capacity in COPD
Lead Sponsor:
University College, London
Collaborating Sponsors:
Nutricia, Inc.
Conditions:
COPD
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a common smoking-related lung disease. Pulmonary Rehabilitation (PR) is a six-week supervised group exercise and education class. PR is an effective in...
Eligibility Criteria
Inclusion
- Confirmed COPD (post-bronchodilator forced vital capacity in one second: forced vital capacity ratio \<0.7)
- \>10 smoking pack year history.
- Enrolling on a pulmonary rehabilitation programme.
- Age of 18 and above.
Exclusion
- Patients with any physical or mental health disorders preventing compliance with trial protocol.
- Unable to communicate in English
- Malabsorption syndrome
- Unable to perform the Incremental Shuttle Walk Test
- Patients already using other types of oral dietary supplement, under the care of a dietitian.
- Galactosaemia (contraindication)
- Known cow's milk protein allergy or lactose intolerance
- BMI \>30kg/m2 without recent weight loss of \>5%
Key Trial Info
Start Date :
January 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 2 2020
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04027413
Start Date
January 7 2019
End Date
October 2 2020
Last Update
October 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central and North West London Foundation Trust
London, United Kingdom, NW1 0PE